-
This new evidence-based guidance from the CDC will improve and streamline how we provide contraceptive services to our patients, says Andrew Kaunitz, MD
-
An experimental levonorgestrel 20 mcg intrauterine device (LNG20 IUD) is under development by Medicines360, a San Francisco-based nonprofit pharmaceutical company.
-
Increasing the capacity of U.S. clinicians to provide high quality sexual and reproductive health (SRH) care for all Americans is an urgent public health priority, and proponents are working fast to implement new strategies to meet the need.
-
-
Integrating sexual and reproductive health (SRH) into public health and primary care is one of those vexing problems: complex, multifaceted, and requiring disparate groups to work together to develop strategies and policy activities that align pre-licensure SRH education, continuing professional development, and service delivery for all healthcare professionals within an integrated primary healthcare framework.
-
Good news: Recent data from the Centers for Disease Control and Prevention (CDC) show that teen birth rates fell at least 15% for all but two states (North Dakota and West Virginia) during 2007-2011, with rates falling 30% or more in seven states: Arizona, Colorado, Florida, Idaho, Minnesota, Nevada, and Utah.
-
-
-
-
The Centers for Disease Control and Prevention (CDC) released its first U.S. Selected Practice Recommendations for Contraceptive Use (US SPR) in the June 21, 2013, Morbidity and Mortality Weekly Report. These practice recommendations address common, yet complex, issues surrounding initiating and using several contraceptive methods, and they serve as a resource for clinicians, including those who care for adolescents.
